These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 946209)
21. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
22. Antibody response to a human diploid cell rabies vaccine. Cabasso VJ; Dobkin MB; Roby RE; Hammar AH Appl Microbiol; 1974 Mar; 27(3):553-61. PubMed ID: 4856855 [TBL] [Abstract][Full Text] [Related]
23. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. Pappaioanou M; Fishbein DB; Dreesen DW; Schwartz IK; Campbell GH; Sumner JW; Patchen LC; Brown WJ N Engl J Med; 1986 Jan; 314(5):280-4. PubMed ID: 3510393 [TBL] [Abstract][Full Text] [Related]
24. The present status of rabies vaccine development and clinical experience with rabies vaccine. Roumiantzeff M Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767 [TBL] [Abstract][Full Text] [Related]
26. [Study of revaccination with primary hamster kidney cell rabies vaccine in human beings and its possibility of pre-exposure prevention of rabies]. Chen X Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Dec; 12(6):331-4. PubMed ID: 1811890 [TBL] [Abstract][Full Text] [Related]
27. Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination. Bernard KW; Mallonee J; Wright JC; Reid FL; Makintubee S; Parker RA; Dwyer DM; Winkler WG JAMA; 1987 Feb; 257(8):1059-63. PubMed ID: 3806894 [TBL] [Abstract][Full Text] [Related]
29. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells. Dong G; Zheng H; Liu Z Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018 [TBL] [Abstract][Full Text] [Related]
30. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans. Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504 [TBL] [Abstract][Full Text] [Related]
31. Zonal-centrifuged purified duck embryo cell culture rabies vaccine for human vaccination. Lavender JF; Van Frank RM Appl Microbiol; 1971 Sep; 22(3):358-65. PubMed ID: 5119204 [TBL] [Abstract][Full Text] [Related]
32. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642 [TBL] [Abstract][Full Text] [Related]
33. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity study of abbreviated rabies preexposure vaccination schedules. Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473 [TBL] [Abstract][Full Text] [Related]
35. Booster effect of human diploid cell antirabies vaccine in previously treated persons. Fayaz A; Simani S; Nour-Salehi S; Bahmanyar M JAMA; 1981 Nov; 246(20):2334-5. PubMed ID: 7299954 [TBL] [Abstract][Full Text] [Related]
36. The primary hamster kidney cell rabies vaccine: adaptation of viral strain, production of vaccine, and pre- and postexposure treatment. Lin F; Zeng F; Lu L; Lu X; Zen R; Yu Y; Chen N J Infect Dis; 1983 Mar; 147(3):467-73. PubMed ID: 6833794 [TBL] [Abstract][Full Text] [Related]
37. Clinical use of human globulin immune to rabies virus. Hattwick MA; Corey L; Creech WB J Infect Dis; 1976 Jun; 133 Suppl():A266-72. PubMed ID: 932504 [TBL] [Abstract][Full Text] [Related]
38. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Lodmell DL; Esposito JJ; Ewalt LC Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356 [TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases. Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]